Chemoinformaics analysis of 9H-Xanthen-9-one, 2-hydroxy-3-methoxy-
Molecular Weight | 242.23 | nRot | 1 |
Heavy Atom Molecular Weight | 232.15 | nRig | 17 |
Exact Molecular Weight | 242.058 | nRing | 3 |
Solubility: LogS | -3.635 | nHRing | 1 |
Solubility: LogP | 2.885 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 14 |
No. of Oxygen atom | 4 | No. of Arom Bond | 16 |
nHA | 4 | APOL | 33.2559 |
nHD | 1 | BPOL | 14.3721 |
QED | 0.666 |
Synth | 1.96 |
Natural Product Likeliness | 0.712 |
NR-PPAR-gamma | 0.101 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.01 |
Pgp-sub | 0.951 |
HIA | 0.005 |
CACO-2 | -4.809 |
MDCK | 0.0000204 |
BBB | 0.166 |
PPB | 0.906437 |
VDSS | 0.605 |
FU | 0.114461 |
CYP1A2-inh | 0.965 |
CYP1A2-sub | 0.947 |
CYP2c19-inh | 0.678 |
CYP2c19-sub | 0.251 |
CYP2c9-inh | 0.525 |
CYP2c9-sub | 0.89 |
CYP2d6-inh | 0.554 |
CYP2d6-sub | 0.888 |
CYP3a4-inh | 0.359 |
CYP3a4-sub | 0.274 |
CL | 3.925 |
T12 | 0.653 |
hERG | 0.059 |
Ames | 0.78 |
ROA | 0.194 |
SkinSen | 0.919 |
Carcinogencity | 0.735 |
EI | 0.977 |
Respiratory | 0.405 |
NR-Aromatase | 0.692 |
Antiviral | Yes |
Prediction | 0.624294 |